From the Department of Orthopedic Surgery, NYU Langone Health, New York, NY.

Dr. Leucht or an immediate family member has received royalties from Springer; serves as a paid consultant to Ankasa Regenerative Therapeutics and Stryker; has stock or stock options held in Ankasa Regenerative Therapeutics; has received nonincome support (such as equipment or services), commercially derived honoraria, or other non-research–related funding (such as paid travel) from Springer; serves as a board member, owner, officer, or committee member of the Orthopaedic Trauma Association and AAOS. Neither Dr. Mehta nor any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article.

This technology overview was approved by the American Academy of Orthopaedic Surgeons Board of Directors on December 1, 2023.